BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6729204)

  • 1. [Omeprazole and inhibition of gastric acid secretion].
    Rossi G
    Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 6. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB
    Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
    Modlin IM
    Recenti Prog Med; 2001; 92(7-8):456-61. PubMed ID: 11475787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.
    McArthur KE; Collen MJ; Maton PN; Cherner JA; Howard JM; Ciarleglio CA; Cornelius MJ; Jensen RT; Gardner JD
    Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
    Fiasse R; Tomé G; Dive C
    Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole in the Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M; Alcabes G; Lehy T; Nguyen Phuoc BK; Vatier J; Bonfils S
    Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omeprazole: effects and side effects].
    Hengels KJ
    Z Gastroenterol; 1984 May; 22(5):241-3. PubMed ID: 6741201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Omeprazole. A new substance for inhibiting acid production].
    Uhl D
    Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a need for strong gastric acid inhibition in clinical practice?
    Lamers CB
    Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitors of proton pump in the treatment of Zollinger-Ellison syndrome].
    Kubyshkin VA; Kochatkov AV
    Khirurgiia (Mosk); 2012; (12):67-71. PubMed ID: 23323285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.